Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis
- 1 October 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Infectious Diseases
- Vol. 21 (5), 483-488
- https://doi.org/10.1097/qco.0b013e32830d0ee8
Abstract
Purpose of review To identify recent papers showing how human and parasite genetics influence leishmaniasis, and how understanding of the immunopathology may be utilized in immunotherapy for these diseases. Recent findings Progress has been made in recent years showing the complexity within populations of Leishmania spp. and indicating that different strains lead to diverse clinical pictures and responses to treatment. Thus detection of parasite genetic tags for the precise identification of infecting strains, and for predictive diagnosis of clinical and therapeutic fates seems now possible. Host genetic loci involved in disease outcome have been detected, which may also be explored for better case management. These developments in diagnosis will demand expanding the therapeutic arsenal to take their expected effect. This is starting to be fulfilled by immunotherapies successfully employed to treat cases refractory to standard first line drugs, as the result of a more profound comprehension of the immunopathology of the leishmaniases. Summary The knowledge mounting has already helped explain why different patients present different forms of leishmaniasis and respond differently to treatment, and may be on the verge of catalyzing a major change in the already over a century old paradigm of diagnosing and managing these patients.Keywords
This publication has 60 references indexed in Scilit:
- Roles of Trypanothione S -Transferase and Tryparedoxin Peroxidase in Resistance to AntimonialsAntimicrobial Agents and Chemotherapy, 2008
- Genetic Predisposition to Self‐Curing Infection with the ProtozoanLeishmania chagasi:A Genomewide ScanThe Journal of Infectious Diseases, 2007
- Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugsZeitschrift für Parasitenkunde, 2007
- Can interferon-γ and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?Clinical and Experimental Immunology, 2007
- Y Chromosome Lineage- and Village-Specific Genes on Chromosomes 1p22 and 6q27 Control Visceral Leishmaniasis in SudanPLoS Genetics, 2007
- Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesisParasite Immunology, 2007
- Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasisThe Journal of Experimental Medicine, 2007
- Oral Pentoxifylline Combined with Pentavalent Antimony: A Randomized Trial for Mucosal LeishmaniasisClinical Infectious Diseases, 2007
- Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica ParasitesPLoS Medicine, 2006
- The Strange Case of Leishmania chagasiParasitology Today, 2000